Safety, Tolerability, and Pharmacokinetics of Modified and Immediate Release Anatabine Citrate Formulations

NCT02432313 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics of Anatabine

Interventions

DRUG: Modified Release Formulation x (MRx)

Sponsor

Rock Creek Pharmaceuticals, Inc.